Clinical Services
High-Risk Drug Monitoring
We give practices assurance that patients on high-risk medicines are monitored to protocol. We validate registers, identify overdue monitoring, manage recall to completion, review results against shared-care protocols and hand over an SOP so monitoring stays on track.
At a glance
- Delivery mode
- Remote, in person or hybrid
- Availability
- 7 days, 6am to 10pm
- Funding routes
- Project fee · Retainer · PCN ARRS
- Staffing
- Pharmacist independent prescribers and pharmacy technicians
Who this is for
Practices and PCNs who need assurance that patients on high-risk medicines (for example DMARDs, lithium, anticoagulants, amiodarone) are monitored to protocol.
What's included
- Register validation and coding clean-up
- Identification of overdue monitoring
- Recall and follow-up managed to completion
- Review of results against shared-care protocols and local guidance
- Liaison with secondary care where shared care is in place
- Audit report with per-drug compliance rates
- SOP for ongoing monitoring handed to the practice
How it works for this service
- 01
Validate registers
We confirm who is on each high-risk medicine and correct coding.
- 02
Recall overdue patients
Overdue monitoring is identified and recalled to completion.
- 03
Review results
Results are reviewed against shared-care protocols and acted on.
- 04
Hand over
You receive an audit report and an SOP for ongoing monitoring.
Outcomes we work towards
Evidence-ready monitoring compliance
Reduced risk of avoidable harm
Clear ownership of each monitoring step
Governance
Monitoring follows local shared-care agreements and national guidance. Abnormal results are acted on by pharmacist independent prescribers or escalated to the responsible clinician.